Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist
US10112981B2 · kind B2 · utility
1Cited by
1References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 15, 2016 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Nov 15, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/57536
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using an ETB receptor agonist, such as IRL-1620, for the treatment of stroke or cerebrovascular accidents are disclosed. The ETB receptor agonist is used alone or in combination with a second agent useful in the treatment of stroke or other cerebrovascular accident.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.